Details for Patent: 11,311,515
✉ Email this page to a colleague
Which drugs does patent 11,311,515 protect, and when does it expire?
Patent 11,311,515 protects UPNEEQ and is included in one NDA.
This patent has twenty-three patent family members in sixteen countries.
Summary for Patent: 11,311,515
| Title: | Oxymetazoline compositions |
| Abstract: | The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage. |
| Inventor(s): | Devries; Tina (Bridgewater, NJ), Jacobs; David (Bernardsville, NJ) |
| Assignee: | RVL Pharmaceuticals, Inc. (Bridgewater, NJ) |
| Application Number: | 17/461,052 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; |
Drugs Protected by US Patent 11,311,515
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rvl Pharms | UPNEEQ | oxymetazoline hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 212520-001 | Jul 8, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,311,515
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2020268329 | ⤷ Sign Up | |||
| Brazil | 112021022404 | ⤷ Sign Up | |||
| Canada | 3139443 | ⤷ Sign Up | |||
| Chile | 2021002918 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
